Standout Papers

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone a... 2022 2026 2023 202496
  1. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (2022)
    Christina Tsien, Stephanie L. Pugh et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Glioblastoma Therapy: Past, Present and Future
2024 Standout
Glioma
2024 Standout

Works of Kevin Oh being referenced

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
2022 Standout
Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Kevin Oh 1126 922 714 803 88 2.7k
Maurizio Amichetti 1025 581 850 707 133 3.0k
Omar M. Salazar 1159 747 689 617 84 2.5k
Richard S. Cox 1296 367 764 744 77 3.5k
P N Plowman 765 390 947 715 93 2.7k
Minhee Won 1340 1905 511 515 62 3.4k
R. D. T. Jenkin 1269 1580 693 894 57 4.2k
Rolf‐Peter Mueller 1813 953 635 1073 36 2.6k
James E. Marks 1156 636 1064 1018 61 3.0k
Juergen Dunst 1499 458 1471 1143 117 3.9k
P. Rubin 1010 680 628 411 83 2.5k

All Works

Loading papers...

Rankless by CCL
2026